Traditionally, medicinal research has focused on small agents, but peptidic partners are rapidly gaining traction. This innovative strategy utilizes combining peptides with complementary therapeutic modalities to confront intricate illness pathways. By leveraging the distinctive features of peptides – such as significant selectivity and delivery